Kawai Taketo

カワイタケト | Kawai Taketo

Affiliation and department：
Job title： Professor
Other affiliations (1)：

Research field (1)： Urology

Research keywords (4)： Renal pelvic and ureteral cancer , Urothelial carcinoma , Bladder cancer , Prostate cancer

Research theme for competitive and other funds (9)：

2025 - 2028 Development of a Novel Therapy for Invasive Bladder Cancer Using Ultrasound-Responsive Microbubbles
2021 - 2026 Fluorescent Substrates for Cancer Detection Using Clinical Specimens and Animal Models Aiming for Negative Margin of Prostate Cancer Surgery
2023 - 2025 バブル製剤を用いた浸潤性膀胱癌に対する超音波治療機器の開発
2023 - 2025 G8・VES-13のWebアンケートシステムの構築
2021 - 2024 尿路上皮における遺伝子変異の蓄積と癌化のメカニズムの解明

Show all

Papers (173)：

Taketo Kawai, Kazuki Maki, Satoru Taguchi, Yoichi Fujii, Takehiro Tanaka, Jimpei Miyakawa, Jun Kamei, Shigenori Kakutani, Aya Niimi, Daisuke Yamada, et al. Efficacy of Early Switching From Docetaxel to Cabazitaxel in Castration-Resistant Prostate Cancer. The Prostate. 2025
Taketo Kawai, Kazuki Honda, Satoru Taguchi. Reply to “Critical Appraisal of ‘Impact and Risk Factors of Diagnostic Delay in Patients With Testicular Cancer: A Multicenter Retrospective Study’”. International Journal of Urology. 2025
Yoshiaki Kurokawa, Taketo Kawai, Satoru Taguchi, Kazuki Honda, Kazuki Maki, Yoshiki Ambe, Naoki Saegusa, Masahiro Yamamoto, Yuumi Tokura, Kazuki Yanagida, et al. Predictive ability of the geriatric 8 screening tool for treatment completion of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy in patients with urothelial carcinoma. Japanese Journal of Clinical Oncology. 2025
Taketo Kawai, Satoru Taguchi, Tohru Nakagawa, Haruki Kume. Local therapy for oligometastatic prostate cancer. Japanese Journal of Clinical Oncology. 2025
Satoru Taguchi, Taketo Kawai, Yoshiaki Kurokawa, Naoki Saegusa, Masahiro Yamamoto, Yoshiki Ambe, Kazuki Honda, Kazuki Maki, Yoichi Fujii, Jimpei Miyakawa, et al. The first real-world evidence on dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin followed by switch maintenance avelumab in advanced urothelial carcinoma: a propensity score-matched study. International Journal of Clinical Oncology. 2025

ｍore...

MISC (118)：

ｍore...

Education (3)：

Work history (5)：

2024/04 - 現在 International University of Health and Welfare Ichikawa Hospital Department of Urology Professor
2022/01 - 現在 Graduate School of Medicine, The University of Tokyo Department of Urology
2022/01 - 2024/03 Teikyo University School of Medicine Department of Urology Lecturer
2018/04 - 2021/12 Graduate School of Medicine, The University of Tokyo Department of Urology Lecturer
2016/04 - 2018/03 Graduate School of Medicine, The University of Tokyo Department of Uroloy Assistant professor

Awards (3)：

2023/11 - テルモ生命科学振興財団研究開発助成金バブル製剤を用いた浸潤性膀胱癌に対する超音波治療機器の開発
2023/06 - 日本老年泌尿器科学会研究助成金 G8・VES-13のWebアンケートシステムの構築
2012/02 - European Association of Urology Best Poster Award Aberration of a cell adhesion molecule, CADM1, and its pathological or biological significance in urinary bladder cancer

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page